New vaccine is effective against all and any emerging variants of Covid-19 and SARS
Researchers at the Walter Reed Army Institute of Research will announce in 2022 that they have developed a super vaccine that is effective against all and any emerging variants of Covid.
Called the Walter Reed’s Spike Ferritin Nanoparticle COVID-19 vaccine, or SpFN it uses a soccer ball-shaped protein with 24 faces for its vaccine, which allows scientists to attach the spikes of multiple coronavirus strains on different faces of the protein.
Dr. Kayvon Modjarrad, director of Walter Reed’s infectious diseases branch, said in an exclusive interview with Defense One the SpFN completed animal trials earlier this year with positive results. Phase 1 of human trials, which tested the vaccine against Omicron and the other variants, wrapped up this month, again with positive results that are undergoing final review.
“It’s very exciting to get to this point for our entire team and I think for the entire Army as well, the likelihood this generation will see another pandemic during its lifetime “is high” we have seen the acceleration of these pathogens and the epidemics that they precipitate. And it may not be a coronavirus, this may not be the big one. There may be something that’s more transmissible and more deadly ahead of us.”
“We have to think more broadly, not just about COVID-19, not just about coronavirus, but all emerging infectious threats coming into the future.”
Dr. Dimitra Stratis-Cullum, director of the Army’s transformational synthetic-biology for military environments program at the U.S. Army Combat Capabilities Development Command also said “We don’t want to just treat what’s in front of us now, I think we really need to be resilient. From an Army perspective. We need to be agile, we need to adapt to the threat that we don’t know that’s coming.”
Source Defence One
- Click to share on Facebook (Opens in new window)
- Click to share on X (Opens in new window)
- Click to print (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to email a link to a friend (Opens in new window)
- Click to share on Mastodon (Opens in new window)
- Click to share on Nextdoor (Opens in new window)